Further insight into the Zn2+-mediated binding of streptonigrin to DNA

Farmaco

Volumn 53, Issue 10-11, 1998, Pages 645-649

  Marcazzan, Michele ^a   Gatto, Barbara ^a   Sissi, Claudia ^a   Zagotto, Giuseppe ^a   Capranico, Giovanni ^b,c   Palumbo, Manlio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

2:1 complex; DNA; Streptonigrin; Zinc

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DNA; DOUBLE STRANDED DNA; RUFOCROMOMYCIN; SINGLE STRANDED DNA; ZINC ION;

ARTICLE; CIRCULAR DICHROISM; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DNA BINDING; SPECTROPHOTOMETRY;

EID: 0032454611     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(98)00080-9     Document Type: Article

References (13)

1. J.J. Oleson, L.A. Caldarella, K.J. Mjos, A.R. Reith, R.S. Thie, I. Topin, The effects of streptonigrin on experimental tumors, Antibiot. Chemother. 11 (1961) 158-164.
2. W. De Graff, S.M. Hahn, J.B. Mitchell, M.C. Krishna, Free radical modes of cytotoxicity of adriamycin and streptonigrin, Biochem. Pharmacol. 48 (1994) 1427-1435.
3. S.B. Yee, C.A. Pritsos, Comparison of oxygen radical generation from the reductive activation of doxorubicin, streptonigrin, and menadione by xanthine oxidase and xanthine dehydrogenase, Arch. Biochem. Biophys. 347 (1997) 235-241.
4. Y. Yamashita, S. Kawada, N. Fujii, H. Nakano, Induction of mammalian DNA topoisomerase II dependent DNA cleavage by antitumor antibiotic streptonigrin, Cancer Res. 50 (1990) 5841-5844.
5. G. Capranico, M. Palumbo, S. Tinelli, F. Zunino, Unique sequence specificity of topoisomerase II DNA cleavage stimulation and DNA binding mode of streptonigrin, J. Biol. Chem. 269 (1994) 25004-25009.
6. M.M. Harding, G.V. Long, Interaction of the antitumour antibiotic streptonigrin with metal ions and DNA, Curr. Med. Chem. 4 (1997) 405-420.
7. G.V. Long, M.M. Harding, J.Y. Fan, W.A. Denny, Interaction of the antitumour antibiotic streptonigrin with DNA and oligonucleotides, Anticancer Drug Des. 12 (1997) 453-472.
8. G.V. Long, M.M. Harding, M.C.L. Xie, I.E. Buys, T.W. Hambley, 3-Amino-6,6′-bis(methoxycarbonyl)-2,2′-bipyridine, a model for the central chelation unit of streptonigrin, J. Chem. Soc. Dalton Trans. (1995) 951-955.
9. G.V. Long, M.M. Harding, A proton nuclear magnetic resonance study of the interaction of zinc(II) with the antitumour drug streptonigrin, J. Chem. Soc. Dalton Trans. (1996) 549-552.
10. A. Moustatih, A. Garnier-Suillerot, Bifunctional antitumor compounds: synthesis and characterization of a Au(III)-streptonigrin complex with thiol-modulating properties, J. Med. Chem. 32 (1989) 1426-1431.
11. G.L. Eichhorn, The effect of metal ions on the structure and function of nucleic acids, Adv. Inorg. Chem. 3 (1981) 1-46.
12. B.K. Sinha, Irreversible binding of reductively activated streptonigrin to nucleic acids in the presence of metals, Chem. Biol. Interact. 36 (1981) 179-188.
13. X. Gao, P. Mirau, D.J. Patel, Structure refinement of the chromomycin dimer-DNA complex in solution, J. Mol. Biol. 223 (1992) 259-279.